Robert Sarrazin

Chief Investment Officer and Managing Partner

9 past transactions

SpectrumAi

Seed Round in 2022
SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize.

Cortica

Venture Round in 2022
Cortica provides diagnoses for autism, ADHD, developmental delays, and developmental differences. They offer in-home, in-clinic, and telehealth services. Their services include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, music therapy, and more.

Suggestic

Venture Round in 2021
Suggestic's platform enables health-related organizations to build and deliver personalized nutrition programs in a fraction of the time and cost through white label solutions or direct API integration. Powered by proprietary artificial intelligence, the Suggestic platform allows for the encoding of dietary programs as rulesets. It then enables data acquisition from users and members in the form of assessments, lab tests, and devices. Based on the rulesets of the program and the user data, the platform delivers personalized food recommendations in the form of meal plans, smart shopping lists, recipe and restaurant recommendations, food logging, and more.

Floreo

Venture Round in 2021
Floreo is a virtual reality therapy system for autism, ADHD and anxiety therapy. Floreo is now used by over 100 therapy clinic businesses and school districts. We're a trail blazer for digital therapeutic reimbursement as the first VR behavioral health company w/ an approved CPT 3 reimbursement code. And we're partnered with Meta to help bring Floreo VR to public schools.

Yamo Pharmaceuticals

Venture Round in 2021
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

BioROSA Technologies

Venture Round in 2021
BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders. The company was founded in 2018 and is based in Belmont, Massachusetts.

SpectrumAi

Venture Round in 2021
SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize.

Axial Biotherapeutics

Series C in 2021
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders.

Joshin

Seed Round in 2021
We guide and support companies, employees, and their families in all aspects of disability and neurodivergence through specialized care, virtual coaching, and disability education.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.